Tien-Yuan Wu

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Hepatitis B Virus

Top Venues

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Integrative cancer therapies

Tzu Chi University

Rutgers The State University of New Jersey (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Tzu Chi University Mar 1o 2015

Taiwan

Assistant Professor :: Pharmacology

Education History

Rutgers The State University of New Jersey

United States

PHD :: Pharmacy/Pharmaceutical Science

Publications

Hui-Hsia Hsieh, Tien-Yuan Wu, Chi-Hua Chen, Yu-Hung Kuo, Mann-Jen Hour
Survival Outcomes of Calcium Channel Blocker Therapy in Patients With Non-Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor Inhibitors: A Retrospective Study. Integrative cancer therapies 22 (2023)
Hui-Hsia Hsieh, Tien-Yuan Wu, Chi-Hua Chen, Mann-Jen Hour
Cost-effectiveness and clinical outcomes of intermittent/continuous proton pump inhibitors infusion in high bleeding risk of ulcers: A retrospective observational cohort study. Medicine 100 (49) (2022)
Chi-Hua Chen, Hui-Hsia Hsieh, Tien-Yuan Wu
Real-world prevalence of hepatitis B virus reactivation in cancer patients in Taiwan. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 27 (1) (2020)
Tien-Yuan Wu, Jia-Ni Lin, Zi-Yao Luo, Chuan-Jen Hsu, Jen-Shu Wang, Hung-Pin Wu
2,3,4',5-Tetrahydroxystilbene-2-O-β-D-Glucoside (THSG) Activates the Nrf2 Antioxidant Pathway and Attenuates Oxidative Stress-Induced Cell Death in Mouse Cochlear UB/OC-2 Cells. Biomolecules 10 (3) (2020)